about
c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology.Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Targeting angiogenesis in advanced cervical cancer.
@ast
Targeting angiogenesis in advanced cervical cancer.
@en
Targeting angiogenesis in advanced cervical cancer.
@nl
type
label
Targeting angiogenesis in advanced cervical cancer.
@ast
Targeting angiogenesis in advanced cervical cancer.
@en
Targeting angiogenesis in advanced cervical cancer.
@nl
prefLabel
Targeting angiogenesis in advanced cervical cancer.
@ast
Targeting angiogenesis in advanced cervical cancer.
@en
Targeting angiogenesis in advanced cervical cancer.
@nl
P2860
P356
P1476
Targeting angiogenesis in advanced cervical cancer.
@en
P2093
Krishnansu S Tewari
Ramez N Eskander
P2860
P304
P356
10.1177/1758834014543794
P577
2014-11-01T00:00:00Z